MedTrace Logo

Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)

NCT05208788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2023-11-29

No results posted yet for this study

Summary

This study aims to test and validate the panel of study urinary biomarker to assess whether (1) reference values differ between paediatric renal transplant patients, patients with chronic kidney disease stage IV and V (CKD IV-V) and children without any disease, (2) characteristic changes in concentration profile may be observed after event-specific injury, (3) differences between paediatric renal transplant patients with AR and other causes of AKI can be detected, and (4) stratification of renal transplant patients to different histological types of AR is possible.

Conditions

  • Renal Transplantation
  • Chronic Kidney Insufficiency
  • Healthy Controls

Interventions

DIAGNOSTIC_TEST

Biomarker test

collection of 500µl to 1 ml of a spot urine sample

Sponsors & Collaborators

  • Natural and Medical Sciences Institute (NMI)

    collaborator UNKNOWN

  • Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

    collaborator UNKNOWN

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Marcus Weitz, PD Dr. med. · University Children's Hospital Tuebingen

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-02-01
Completion
2023-02-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208788 on ClinicalTrials.gov